ArticleObesity surgery2026
Development and Internal Validation of a Nomogram for Predicting Reflux Esophagitis in Candidates for Metabolic Bariatric Surgery.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundReflux esophagitis (RE) is common among individuals with obesity and candidates for Metabolic Bariatric Surgery (MBS). Therefore, this study aimed to develop and internally evaluate a clinical nomogram to estimate the risk of RE in candidates for MBS.
methodsA total of 694 patients scheduled for MBS between July 2020 and December 2023 were retrospectively enrolled and randomly split into a training set and an internal test set at a 7:3 ratio. All patients underwent preoperative upper gastrointestinal endoscopy to assess RE status. The least absolute shrinkage and selection operator (LASSO) regression was applied to identify candidate predictors. Variables with non-zero coefficients were subsequently entered into multivariable logistic regression analysis, and independent factors were used to construct the nomogram. Model discrimination, calibration, and clinical utility were evaluated using the concordance index (C-index), calibration curves, and decision curve analysis (DCA), respectively.
resultsThe overall prevalence of RE was 20.03%. Multivariable logistic regression analysis identified age, BMI, HDL-C, sex, and Helicobacter pylori (H. pylori) infection status as independent factors associated with RE. The nomogram constructed based on these variables demonstrated acceptable predictive performance in both sets. The area under the curve (AUC) was 0.796 in the training set and 0.79 in the internal test set. After bootstrap internal validation with 1,000 resamples in the training set, the bias-corrected C-index was 0.786. Calibration curves showed acceptable agreement between predicted probabilities and the observed incidence of RE.
conclusionsWe developed a concise nomogram incorporating preoperative clinical variables to estimate the risk of RE in candidates for MBS. The model demonstrated acceptable discrimination and calibration based on internal validation; however, its clinical applicability requires further external validation.
Indexed as
Identifiers
42277448What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.